Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droglican versus placebo for symptomatic hand osteoarthritis
2016-000998-20Phase 4Completed
- Sponsor
- Bioiberica
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Droglican, chondroitin sulfate and glucosamine sulphate in hand osteoarthritis (2 arms), sponsored by Bioiberica. Primary endpoint: Change in spontaneous hand pain. Started Apr 2016; status: completed.
02
Drugs
Droglicanchondroitin sulfateglucosamine sulphate
03
Conditions
hand osteoarthritis
Beyond the preview
Go deeper on 2016-000998-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000998-20.